Clinical Trial

A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

Name: A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women — clinical trial record (NCT07305779)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the effect of cytochrome P450 isoenzyme 2D6 (CYP2D6) inhibition by quinidine on the pharmacokinetic (PK) parameters of a single dose SEP-380135 in healthy adult participants.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-12.

Trial Details

NCT Number	NCT07305779
Lead Sponsor	Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions	Schizophrenia
Enrollment	12 participants
Start Date	2025-03-07
Primary Completion	2025-05-03 (estimated)
Study Completion	2025-05-03 (estimated)
Updated on ClinicalTrials.gov	2026-01-15